Durable Polymer Versus Biodegradable Polymer Drug-Eluting Stents in Acute Coronary Syndrome Patients With High Ischemic Risk: Three-Year Post Hoc Analysis of the HOST-REDUCE-POLYTECH-ACS Trial

被引：0
|
作者：
Han, Seokmoon [1 ]
Hwang, Doyeon [1 ]
Kang, Jeehoon [1 ]
Park, Kyung Woo [1 ]
Han, Jung-Kyu [1 ]
Yang, Han-Mo [1 ]
Kang, Hyun-Jae [1 ]
Koo, Bon-Kwon [1 ]
Kim, Hyo-Soo [1 ]
机构：
[1] Seoul Natl Univ Hosp, Seoul, South Korea
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2024年 / 84卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
TCT-431
引用
收藏
页码：B127 / B128
页数：2
相关论文
共 50 条
  • [31] Impact of biodegradable versus durable polymer drug-eluting stents on clinical outcomes in patients with coronary artery disease: a meta-analysis of 15 randomized trials
    Zhang Yaojun
    Tian Nailiang
    Dong Shengjie
    Ye Fei
    Li Minghui
    Bourantas, Christos V.
    Iqbal, Javaid
    Onuma, Yoshinobu
    Muramatsu, Takashi
    Diletti, Roberto
    Garcia-Garcia, Hector M.
    Xu Bo
    Serruys, Patrick W.
    Chen Shaoliang
    CHINESE MEDICAL JOURNAL, 2014, 127 (11) : 2159 - 2166
  • [32] The impact of biodegradable versus durable polymer drug-eluting stents on stent thrombosis in patients with coronary artery disease: a meta-analysis of 15 randomized trials
    Zhang, Yao-Jun
    Iqbal, Javaid
    Bourantas, Christos
    Chen, Shao Liang
    Garcia-Garcia, Hector
    Muramatsu, Takashi
    Serruys, Patrick W.
    Dong Sheng-Jie
    Xu, Bo
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (18) : B252 - B252
  • [33] Two-year clinical outcomes of biodegradable polymer versus durable polymer drug-eluting stent implantation in hemodialysis patients after percutaneous coronary intervention
    Okuno, S.
    Ishihara, T.
    Iida, O.
    Asai, M.
    Masuda, M.
    Okamoto, S.
    Nanto, K.
    Kanda, T.
    Tsujimura, T.
    Matsuda, Y.
    Hata, Y.
    Uematsu, H.
    Sato, Y.
    Mano, T.
    EUROPEAN HEART JOURNAL, 2019, 40 : 3848 - 3848
  • [34] Biodegradable versus durable polymer drug eluting stents in coronary artery disease: Insights from a meta-analysis of 5834 patients
    Lupi, Alessandro
    Rognoni, Andrea
    Secco, Gioel Gabrio
    Lazzero, Maurizio
    Nardi, Federico
    Fattori, Rossella
    Bongo, Angelo Sante
    Agostoni, Pierfrancesco
    Sheiban, Imad
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2014, 21 (04) : 411 - 424
  • [35] High Bleeding Risk Patients Treated with Very Thin-Strut Biodegradable Polymer or Thin-Strut Durable Polymer Drug-Eluting Stents in the BIO-RESORT Trial
    Paolo Zocca
    Marlies M. Kok
    Liefke C. van der Heijden
    Peter W. Danse
    Carl E. Schotborgh
    Martijn Scholte
    Marc Hartmann
    Gerard C. M. Linssen
    Carine J. M. Doggen
    Clemens von Birgelen
    Cardiovascular Drugs and Therapy, 2018, 32 : 567 - 576
  • [36] High Bleeding Risk Patients Treated with Very Thin-Strut Biodegradable Polymer or Thin-Strut Durable Polymer Drug-Eluting Stents in the BIO-RESORT Trial
    Zocca, Paolo
    Kok, Marlies M.
    van der Heijden, Liefke C.
    Danse, Peter W.
    Schotborgh, Carl E.
    Scholte, Martijn
    Hartmann, Marc
    Linssen, Gerard C. M.
    Doggen, Carine J. M.
    von Birgelen, Clemens
    CARDIOVASCULAR DRUGS AND THERAPY, 2018, 32 (06) : 567 - 576
  • [37] Long-term safety of ultrathin bioabsorbable-polymer sirolimus-eluting stents versus thin durable-polymer drug-eluting stents in acute coronary syndrome: A systematic review and meta-analysis
    Li, Fadong
    Wang, Shen
    Wang, Yue
    Wei, Can
    Liu, Xinyan
    Sun, Shuaifeng
    Zhao, Wenxin
    Guo, Pengrong
    Wu, Xiaofan
    CLINICAL CARDIOLOGY, 2023, 46 (12) : 1465 - 1473
  • [38] Angiographic and clinical outcomes of patients implanted with ultrathin, biodegradable polymer sirolimus-eluting stents versus durable polymer drug-eluting stents for percutaneous coronary intervention: an updated meta-analysis based on randomized controlled trials
    Liao, Chen
    Liao, Sen
    Liu, Miaoweng
    Xu, Ruoxin
    Peng, Jinhua
    Wei, Yiping
    Zhang, Wenxiong
    JOURNAL OF CARDIOVASCULAR SURGERY, 2021, 62 (02): : 175 - 187
  • [39] Ultrathin Bioresorbable-Polymer Sirolimus-Eluting Stents Versus Thin Durable-Polymer Everolimus-Eluting Stents in Patients Undergoing Coronary Revascularization: Three-Year Outcomes From the Randomized BIOFLOW V Trial
    Kandzari, David E.
    Koolen, Jacques J.
    Doros, Gheorghe
    Garcia-Garcia, Hector M.
    Bennett, Johan
    Roguin, Ariel
    Gharib, Elie G.
    Cutlip, Donald E.
    Waksman, Ron
    JACC-CARDIOVASCULAR INTERVENTIONS, 2020, 13 (04) : S42 - S42
  • [40] Safety and efficacy of the bioabsorbable polymer everolimus-eluting stent versus durable polymer drug-eluting stents in high-risk patients undergoingPCI:TWILIGHT-SYNERGY
    Baber, Usman
    Chandiramani, Rishi
    Mehta, Shamir R.
    Sartori, Samantha
    Zhang, Zhongjie
    Claessen, Bimmer E.
    Briguori, Carlo
    Sharma, Samin
    Dangas, George
    Mehran, Roxana
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2021, 97 (01) : 63 - 71
12345